{"id":21027,"date":"2023-09-21T01:52:04","date_gmt":"2023-09-21T01:52:04","guid":{"rendered":"https:\/\/microloannexus.com\/investing\/atara-biotherapeutics-to-submit-new-fda-biologics-license-application-in-2q\/"},"modified":"2023-09-21T01:52:04","modified_gmt":"2023-09-21T01:52:04","slug":"atara-biotherapeutics-to-submit-new-fda-biologics-license-application-in-2q","status":"publish","type":"post","link":"https:\/\/microloannexus.com\/?p=21027","title":{"rendered":"Atara Biotherapeutics to Submit New FDA Biologics License Application in 2Q"},"content":{"rendered":"<div id=\"js-article__body\" itemprop=\"articleBody\" data-sbid=\"MW-BT-CO-20230919-707076\">\n<div class=\"snippet__body\">\n<p>By Sabela Ojea<\/p>\n<p>Atara Biotherapeutics said it plans to submit a biologics license application for tabelecleucel following productive conversations with the U.S. Food and Drug Administration.<\/p>\n<p>The biopharmaceutical company and the FDA are now aligned and it expects to submit the application in the second quarter of 2024, Atara Biotherapeutics&#8230;\n      <\/p>\n<\/p><\/div>\n<\/div>\n<p>Read the full article <a href=\"https:\/\/www.marketwatch.com\/story\/atara-biotherapeutics-to-submit-new-fda-biologics-license-application-in-2q-388a5d61?mod=investing\" target=\"_blank\" rel=\"noopener\">here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>By Sabela Ojea Atara Biotherapeutics said it plans to submit a biologics license application for tabelecleucel following productive conversations with the U.S. Food and Drug Administration. The biopharmaceutical company and the FDA are now aligned and it expects to submit the application in the second quarter of 2024, Atara Biotherapeutics&#8230; Read the full article here<\/p>\n","protected":false},"author":1,"featured_media":9638,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[49],"tags":[],"class_list":{"0":"post-21027","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-investing"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.12 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Atara Biotherapeutics to Submit New FDA Biologics License Application in 2Q | Micro Loan Nexus<\/title>\n<meta name=\"description\" content=\"By Sabela Ojea Atara Biotherapeutics said it plans to submit a biologics license application for tabelecleucel following productive conversations with the\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/microloannexus.com\/?p=21027\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Atara Biotherapeutics to Submit New FDA Biologics License Application in 2Q | Micro Loan Nexus\" \/>\n<meta property=\"og:description\" content=\"By Sabela Ojea Atara Biotherapeutics said it plans to submit a biologics license application for tabelecleucel following productive conversations with the\" \/>\n<meta property=\"og:url\" content=\"https:\/\/microloannexus.com\/?p=21027\" \/>\n<meta property=\"og:site_name\" content=\"Micro Loan Nexus\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-21T01:52:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/mw_logo_social.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/microloannexus.com\/?p=21027#article\",\"isPartOf\":{\"@id\":\"https:\/\/microloannexus.com\/?p=21027\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/microloannexus.com\/#\/schema\/person\/e2d3b62d35ac325be68540d68dc6660a\"},\"headline\":\"Atara Biotherapeutics to Submit New FDA Biologics License Application in 2Q\",\"datePublished\":\"2023-09-21T01:52:04+00:00\",\"dateModified\":\"2023-09-21T01:52:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/microloannexus.com\/?p=21027\"},\"wordCount\":66,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/microloannexus.com\/#organization\"},\"articleSection\":[\"Investing\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/microloannexus.com\/?p=21027#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/microloannexus.com\/?p=21027\",\"url\":\"https:\/\/microloannexus.com\/?p=21027\",\"name\":\"Atara Biotherapeutics to Submit New FDA Biologics License Application in 2Q | Micro Loan Nexus\",\"isPartOf\":{\"@id\":\"https:\/\/microloannexus.com\/#website\"},\"datePublished\":\"2023-09-21T01:52:04+00:00\",\"dateModified\":\"2023-09-21T01:52:04+00:00\",\"description\":\"By Sabela Ojea Atara Biotherapeutics said it plans to submit a biologics license application for tabelecleucel following productive conversations with the\",\"breadcrumb\":{\"@id\":\"https:\/\/microloannexus.com\/?p=21027#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/microloannexus.com\/?p=21027\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/microloannexus.com\/?p=21027#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/microloannexus.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Atara Biotherapeutics to Submit New FDA Biologics License Application in 2Q\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/microloannexus.com\/#website\",\"url\":\"https:\/\/microloannexus.com\/\",\"name\":\"Solutions For Real\",\"description\":\"Latest Finance News and Updates\",\"publisher\":{\"@id\":\"https:\/\/microloannexus.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/microloannexus.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/microloannexus.com\/#organization\",\"name\":\"Solutions For Real\",\"url\":\"https:\/\/microloannexus.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/microloannexus.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/sf-logo-1.png\",\"contentUrl\":\"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/sf-logo-1.png\",\"width\":690,\"height\":64,\"caption\":\"Solutions For Real\"},\"image\":{\"@id\":\"https:\/\/microloannexus.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/microloannexus.com\/#\/schema\/person\/e2d3b62d35ac325be68540d68dc6660a\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/microloannexus.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1691264579-96x96.png\",\"contentUrl\":\"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1691264579-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/microloannexus.com\"],\"url\":\"https:\/\/microloannexus.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Atara Biotherapeutics to Submit New FDA Biologics License Application in 2Q | Micro Loan Nexus","description":"By Sabela Ojea Atara Biotherapeutics said it plans to submit a biologics license application for tabelecleucel following productive conversations with the","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/microloannexus.com\/?p=21027","og_locale":"en_US","og_type":"article","og_title":"Atara Biotherapeutics to Submit New FDA Biologics License Application in 2Q | Micro Loan Nexus","og_description":"By Sabela Ojea Atara Biotherapeutics said it plans to submit a biologics license application for tabelecleucel following productive conversations with the","og_url":"https:\/\/microloannexus.com\/?p=21027","og_site_name":"Micro Loan Nexus","article_published_time":"2023-09-21T01:52:04+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/mw_logo_social.png","type":"image\/png"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/microloannexus.com\/?p=21027#article","isPartOf":{"@id":"https:\/\/microloannexus.com\/?p=21027"},"author":{"name":"News Room","@id":"https:\/\/microloannexus.com\/#\/schema\/person\/e2d3b62d35ac325be68540d68dc6660a"},"headline":"Atara Biotherapeutics to Submit New FDA Biologics License Application in 2Q","datePublished":"2023-09-21T01:52:04+00:00","dateModified":"2023-09-21T01:52:04+00:00","mainEntityOfPage":{"@id":"https:\/\/microloannexus.com\/?p=21027"},"wordCount":66,"commentCount":0,"publisher":{"@id":"https:\/\/microloannexus.com\/#organization"},"articleSection":["Investing"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/microloannexus.com\/?p=21027#respond"]}]},{"@type":"WebPage","@id":"https:\/\/microloannexus.com\/?p=21027","url":"https:\/\/microloannexus.com\/?p=21027","name":"Atara Biotherapeutics to Submit New FDA Biologics License Application in 2Q | Micro Loan Nexus","isPartOf":{"@id":"https:\/\/microloannexus.com\/#website"},"datePublished":"2023-09-21T01:52:04+00:00","dateModified":"2023-09-21T01:52:04+00:00","description":"By Sabela Ojea Atara Biotherapeutics said it plans to submit a biologics license application for tabelecleucel following productive conversations with the","breadcrumb":{"@id":"https:\/\/microloannexus.com\/?p=21027#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/microloannexus.com\/?p=21027"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/microloannexus.com\/?p=21027#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/microloannexus.com\/"},{"@type":"ListItem","position":2,"name":"Atara Biotherapeutics to Submit New FDA Biologics License Application in 2Q"}]},{"@type":"WebSite","@id":"https:\/\/microloannexus.com\/#website","url":"https:\/\/microloannexus.com\/","name":"Solutions For Real","description":"Latest Finance News and Updates","publisher":{"@id":"https:\/\/microloannexus.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/microloannexus.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/microloannexus.com\/#organization","name":"Solutions For Real","url":"https:\/\/microloannexus.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/microloannexus.com\/#\/schema\/logo\/image\/","url":"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/sf-logo-1.png","contentUrl":"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/sf-logo-1.png","width":690,"height":64,"caption":"Solutions For Real"},"image":{"@id":"https:\/\/microloannexus.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/microloannexus.com\/#\/schema\/person\/e2d3b62d35ac325be68540d68dc6660a","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/microloannexus.com\/#\/schema\/person\/image\/","url":"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1691264579-96x96.png","contentUrl":"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1691264579-96x96.png","caption":"News Room"},"sameAs":["https:\/\/microloannexus.com"],"url":"https:\/\/microloannexus.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/posts\/21027","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microloannexus.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21027"}],"version-history":[{"count":1,"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/posts\/21027\/revisions"}],"predecessor-version":[{"id":21028,"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/posts\/21027\/revisions\/21028"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/media\/9638"}],"wp:attachment":[{"href":"https:\/\/microloannexus.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microloannexus.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/microloannexus.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}